Kestra Medical Technologies, Ltd. Operating Lease, Payments
Kestra Medical Technologies, Ltd. (KMTS) reported Operating Lease, Payments of $544.00 thousand for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-14.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-09-14
- Kestra Medical Technologies, Ltd. operating lease, payments for the quarter ending 2026-07-31 was $544.00K, a 10.79% increase year-over-year.
- Kestra Medical Technologies, Ltd. operating lease, payments for the quarter ending 2026-04-30 was $556.00K, a 273.15% increase year-over-year.
- Kestra Medical Technologies, Ltd. operating lease, payments for the quarter ending 2026-01-31 was $528.00K, a 205.20% increase year-over-year.
- Kestra Medical Technologies, Ltd. operating lease, payments for the quarter ending 2025-10-31 was $506.00K, a 201.19% increase year-over-year.
- Kestra Medical Technologies, Ltd. operating lease, payments for fiscal 2026 was $2.08M, a 217.71% increase from fiscal 2025.
- Kestra Medical Technologies, Ltd. operating lease, payments for fiscal 2025 was $655.00K, a 48.38% decline from fiscal 2024.
- Kestra Medical Technologies, Ltd. operating lease, payments for fiscal 2024 was $1.27M.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2026-07-31 | $544.00K 10-Q · filed 2026-09-14 | $1.10M derived: sum of 2 quarters · filed 2026-09-14 | $1.63M derived: sum of 3 quarters · filed 2026-09-14 | $2.13M derived: sum of 4 quarters · filed 2026-09-14 |
| 2026-04-30 | $556.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | $1.08M derived: sum of 2 quarters · filed 2026-07-14 | $1.59M derived: sum of 3 quarters · filed 2026-07-14 | $2.08M 10-K · filed 2026-07-14 |
| 2026-01-31 | $528.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-03-17 | $1.03M derived: sum of 2 quarters · filed 2026-03-17 | $1.52M 10-Q · filed 2026-03-17 | $1.67M derived: sum of 4 quarters · filed 2026-09-14 |
| 2025-10-31 | $506.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-12-11 | $997.00K 10-Q · filed 2025-12-11 | $1.15M derived: sum of 3 quarters · filed 2026-09-14 | $1.32M derived: sum of 4 quarters · filed 2026-09-14 |
| 2025-07-31 | $491.00K 10-Q · filed 2026-09-14 | $640.00K derived: sum of 2 quarters · filed 2026-09-14 | $813.00K derived: sum of 3 quarters · filed 2026-09-14 | $981.00K derived: sum of 4 quarters · filed 2026-09-14 |
| 2025-04-30 | $149.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | $322.00K derived: sum of 2 quarters · filed 2026-07-14 | $490.00K derived: sum of 3 quarters · filed 2026-07-14 | $655.00K 10-K · filed 2026-07-14 |
| 2025-01-31 | $173.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-03-17 | $341.00K derived: sum of 2 quarters · filed 2026-03-17 | $506.00K 10-Q · filed 2026-03-17 | |
| 2024-10-31 | $168.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-12-11 | $333.00K 10-Q · filed 2025-12-11 | ||
| 2024-07-31 | $165.00K 10-Q · filed 2025-09-12 | |||
| 2024-04-30 | $1.27M 10-K · filed 2025-07-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |